Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience

Christina Matthews, Maryam B. Lustberg, Michael Berger et al.|Journal of Oncology Pharmacy Practice|2019

Cited by 12